Further, in nonalcoholic fatty liver disease mouse models thromboxane A2 (precursor to thromboxane B2) has been shown to contribute to insulin resistance by impairing insulin signaling52. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.